New Study Shows HealthWay Air Cleaners Can Help Improve Cardiovascular Health

• ShareThis Email PDF Print

HealthWay is a world leader in manufacturing of medical-grade air cleaners

We all need to take the proper precautions to create the healthiest indoor environment possible.

Pulaski, NY (PRWEB) August 4, 2010

A recent study conducted by a team of scientists from Denmark and Sweden has shown that breathing filtered, cleaner indoor air can significantly improve cardiovascular health. The study demonstrated that ultrafine particles, common in the air we breathe, affect the performance of blood vessels, potentially increasing the risk of cardiovascular disease. Specifically, the results yielded an improvement in micro-vascular function (MVF) by 8.1 % when using HealthWay air cleaners -- a significant statistical finding.

An increasing number of international medical studies have linked cardiovascular disease to ultrafine particulate matter in the air we breathe. Those at greatest risk include the elderly, the very young, and persons suffering from any cardiorespiratory problems including high blood pressure, heart disease, vascular issues, and asthma.

More recent studies now indicate that when indoor air is continuously filtered and particulate matter of approximately 0.3 microns is removed, medical patients experience improvements in cardiovascular and respiratory health at significant levels.

“Reduction of ultrafine particle exposure by filtration of re-circulated indoor air for only 48 hours improved the MVF in healthy elderly citizens, suggesting that this may be a feasible way of reducing the risk of cardiovascular disease,” explains Dr. Raymond Cipriano, a member of the team that conducted the study published in the American Journal of Respiratory and Critical Care Medicine.

The study utilized air cleaners from HealthWay, a leading international manufacturer of FDA-listed, medical-grade air purification systems located in Upstate New York. “It is absolutely essential that we utilize high quality air cleaners to continuously scrub the air and reduce harmful ultrafine particles,” states Vinny Lobdell, Vice President at HealthWay.

HealthWay air cleaners have been independently tested and shown to capture 100% of all ultrafine particles. It is these ultrafine particles that penetrate deep into the bloodstream and wreak havoc on our bodies. Dr. Cipriano, Senior Scientist for Industry/University Center for Bio-surfaces at the University of Buffalo located in New York, tested and studied HealthWay air cleaners by using a condensation nuclei counter. Condensation nuclei counters are known to measure all airborne particles, right down to even the smallest viruses.

Testing verified that the HealthWay Deluxe model removed all virus-sized particles entering it. The smallest virus particles (the Parovirus) are about 20 nanometers in diameter, or 0.02 microns, far larger than the 3020's minimum activation size. “The results were astounding,” stated Dr. Cipriano.

Other 3rd party testing has also been done on HealthWay air cleaners and their effectiveness in removing ultrafine particles from the air. Last year at the International Healthy Buildings Conference in Syracuse, New York, Philips Corporation, a leader in ultrafine particle measurement instruments, verified with testing at the show that the HealthWay technology captures 100% of ultrafine particles at 0.01 micron. The video is available on YouTube here: http://bit.ly/bpI9NJ .

Air cleaners are no longer solely used by asthmatics and those suffering from allergies. “Increasingly we all are faced with health risks associated with unhealthy indoor air,” adds Mr. Lobdell. “We all need to take the proper precautions to create the healthiest indoor environment possible.”

HealthWay provides air cleaners in many different form factors for residential, commercial and industrial use and they all utilize their patented—and proven—technology in capturing allergens, pollutants, bacteria and viruses.

Dr. Ramond J Cipriano is the Senior Scientist at Industry/University Center for Biosurfaces. IUCB is a 'graduated' Industry/University Cooperative Research Center of the National Science Foundation. Dr. Cipriano is an aerobiology specialist who has spent his life monitoring the events and consequences of human lung-depositable substances. Dr. Cipriano has a MS and PhD in Atmospheric Science, a B.A. in Physics and an M.S. in secondary education Physics.

# # #

Share: